10 assets in Vertebral Column Disorder

Therapeutic assets addressing Vertebral Column Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone Vertebral Column Disorder	AXIS Spine Center- a division of Northwest Specialty Hospital	P4	BB (65)
Marcaine Vertebral Column Disorder	Mayo Clinic	P4	BB (65)
Eukystol Vertebral Column Disorder	Western Michigan University School of Medicine	P4	BB (64)
Methadone Vertebral Column Disorder	The Cleveland Clinic	P4	BB (64)
Ketorolac Vertebral Column Disorder	Western Michigan University School of Medicine	P4	B (63)
Adezunap Vertebral Column Disorder	Apurano Pharmaceuticals GmbH	P3	B (60)
Tizanidine Vertebral Column Disorder	Stanford University	P3	B (60)
Testosterone Cipionate Vertebral Column Disorder	Brigham and Women's Hospital	P2	B (57)
Naproxen Vertebral Column Disorder	Northwestern University	P2	CCC (53)
itx24-01 Vertebral Column Disorder	Interventional AnalgesiX Inc.	P1	NR ()